Pharmaceutical and healthcare market in Poland 2017 Market analysis and development forecasts for 2017-2022

Pharmaceutical and healthcare market in Poland 2017

Market analysis and development forecasts for 2017-2022

The report contains an analysis of the pharmaceutical market covering both pharmacy and hospital sales. The publication also includes a detailed description of sales by Anatomical Therapeutic and Chemical (ATC) classification system. In addition, it presents information regarding the major manufacturers and best-selling products.

 

The report also shows the value of the pharmaceutical (pharmacy and hospital) market, as well as development forecasts from 2017 to 2022, also for ATC categories, and information describing consumer preferences when purchasing drugs and using healthcare services which have an impact on the sales value.

Moreover, the analysis contains detailed data on the Polish healthcare system: number of public and non-public hospitals, bed counts at these facilities, number of doctors by specialisation, value of healthcare spending in Poland and many more.

 

What is the content of the report?

 

  • Value of the pharmaceutical market, pharmacy and hospital segments
     
  • Development forecasts for 2017-2022 – both for the whole market and for pharmacy and hospital channels, including factors having impact on the market now and in the future
     
  • Sales value for the major ATC categories of drugs and sales forecasts between 2017 and 2022
     
  • Growth barriers and stimulants for the whole market and individual drug categories
     
  • Largest pharmaceutical manufacturers operating in Poland – share, sales value, financial performance, future plans
     
  • Best-selling drugs and dietary supplements in Poland
     
  • Detailed analysis of the current legal status, considering possible future legal changes and their market impact
     
  • Comprehensive data on reimbursement, taking into account reimbursement procedure, reimbursement rules, main practical difficulties, reimbursement spending, products with the highest reimbursement rate under open (pharmacy) reimbursement, chemotherapy and drug programmes
     
  • Analysis of the state reimbursement policy, along with presentation of recent changes to lists of reimbursed drugs and possible future expansion directions
     
  • Total NFZ spending on reimbursement, considering ATC classification category, voivodship, patient’s co-payment level
     
  • Analysis of generic substitution
     
  • List of drug programmes existing in Poland with active substances
     
  • Epidemiological trends, including e.g. the most common diseases and most frequent causes of death in Poland
     
  • Consumer behaviour regarding drug purchases and healthcare system use.

 

Who benefits from the analysis? 

 

PMR recommends the publication to management staff and operational personnel at marketing, sales, strategy and development divisions chiefly from the following types of companies:
 

  • financial institutions interested in the pharmaceutical and healthcare market in Poland (banks, brokerage houses, investment funds)
     
  • consulting and research companies, government and academic institutions that monitor the segment
     
  • manufacturers operating in the pharmaceutical market
     
  • drug distributors present in the pharmacy and hospital market (wholesalers, logistics operators, pharmacy chains, retail chains)
     
  • providers of healthcare services in Poland
     
  • marketing agencies serving pharmaceutical and medical companies
     
  • banks.

 

Why to buy the report? 

 

The report is especially helpful in the following situations:

 

  • regular monitoring of development and changes taking place in the pharmaceutical and healthcare market with a view to flexible adjustment of policies and portfolios to the market events and trends
     
  • planning a new investment or making decisions regarding financial support for entities operating in the market
     
  • development of a product portfolio – identification of ATC categories showing the highest growth prospects and already saturated segments
     
  • analysis of investment and credit risk in the market
     
  • performing mergers and acquisitions – identification of the most prospective market areas and entities to be taken over
     
  • analysis of competitors’ current business operations, performance and plans – a quick reaction allowing to keep or increase the market share
     
  • elaborating corporate development strategies and budgets based on original market development forecasts prepared by the team of econometricians and market analysts
     
  • estimating demand for individual categories of drugs now and in the future
     
  • preparing to enter the pharmaceutical or healthcare market in Poland
     
  • launching business operations in new market segments
     
  • essential tool for developing price policy owing to price analysis.
As a London-based company, with operations abroad, we looked for the best-in-class Market Intelligence supplier. PMR brought us quality reports that improved our CEE market knowledge and understanding. Development Manager, GVA Grimley
PMR provides a good service and is always open to discussion. All reports are well structured & are always on time. Member of the Managment Board, SCA Hygiene Products
PMR's analysts understand our needs well and the standard of their service has always fully met our expectations. We are looking forward to cooperating with PMR in the future as well. Senior Trade and Investment Adviser, British Embassy in Warsaw
It's a great pleasure to cooperate with PMR because of its analysts' wealth of experience in understanding the local market. We consider PMR a competent and professional company which helps us conduct our business. I would also like to state that PMR's team is always ready to respond to emerging customer needs. We can recommend it as a reliable partner. Business Analyst, Hilti Distribution, Russia
We use PMR's services due to their analysts' extensive experience in market analysis, their high quality and level of engagement in the market research carried out for us. We consider PMR a competent and professional company and recommend them as a reliable partner in the area of economic information and market analysis. Senior Trade and Investment Adviser, British Embassy in Warsaw
PMR reports are a serious contribution to the market overview picture, focusing our attention on key events in the industry as well as highlighting both general and specific market indicators. Together, these components are the base for our future forecasts of construction market development and help us to plan our sales. Market Analyst, Alpha Cement

  • Overview of the pharmaceutical market in Poland
    • Key trends and events in the previous years
    • Expected events and trends
    • Market value and development forecasts for 2017-2022
      • Pharmacy market
      • Hospital market
  • Pharmaceutical market by therapeutic groups
  • Largest categories – market share and change
  • Alimentary tract and metabolism
    • Category value and development forecasts for 2017-2022
    • Development drivers and barriers
  • Cardiovascular system
    • Category value and development forecasts for 2017-2022
    • Development drivers and barriers
  • Central nervous system
    • Category value and development forecasts for 2017-2022
    • Development drivers and barriers
  • Respiratory system

    • Category value and development forecasts for 2017-2022
    • Development drivers and barriers
    • Cold and flu products
    • Runny nose products
  • Musculoskeletal system
    • Category value and development forecasts for 2017-2022
    • Development drivers and barriers
  • Anti-infectives

    • Category value and development forecasts for 2017-2022
    • Development drivers
  • Genitourinary system
    and barriers
    • Category value and development forecasts for 2017-2022
    • Development drivers and barriers
  • Blood and blood forming organs
    • Category value and development forecasts for 2017-2022
    • Development drivers and barriers
  • Dermatologicals
    • Category value and development forecasts for 2017-2022
    • Development drivers and barriers
  • Antineoplastic and immunomodulating agents
    • Category value and development forecasts for 2017-2022
    • Development drivers and barriers
  • Sensory organs
    • Category value and development forecasts for 2017-2022
    • Development drivers and barriers
  • Systemic hormonal preparations
    • Category value and development forecasts for 2017-2022
    • Development drivers and barriers
    • Category value and development forecasts for 2017-2022
    • Development drivers and barriers
  • Antiparasitic
    • Category value and development forecasts for 2017-2022
    • Development drivers and barriers
  • Bestselling products
    • Total pharmacy market
    • Rx pharmacy market
    • OTC pharmacy market
    • Hospital market
    • Pricing policies
  • Drug reimbursement in Poland
    • Pricing policies
      • VAT rate on drugs
      • Non-reimbursed drugs on the pharmacy market
      • Reimbursed drugs on the pharmacy market
      • Drugs on the hospital market
      • Generic substitution
  • Reimbursement policies
    • Reimbursement system
    • Reimbursement process
    • Fixed NFZ spending on reimbursement and pay-back mechanism
    • Joint-limit groups
    • Market structure
    • Reimbursement spending
    • Latest changes to reimbursement lists
    • Expected changes to drug reimbursement
  • Pharmaceutical companies in Poland
    • Total market
    • Rx market
    • OTC market
    • Profiles of selected key players
    • Economic analysis of the pharmaceutical sector in Poland
      • Production sold
      • Imports and exports
      • Revenues and financial results
      • Employment and salaries
  • Innovativeness of the Polish pharmaceutical sector
    • Innovation active enterprises
    • Activities in the biotechnology segment
    • Clinical trials
  • Epidemiological trends
    • Average life expectancy
    • Most frequent disorders and illnesses
    • Most frequent reasons for hospitalisation
    • Most frequent causes of death
      • Key statistical data
      • Poland compared with other European countries
      • Infant mortality
  • Epidemiology of selected diseases in the Polish society
    • Cardiovascular system diseases
    • Neoplastic diseases
    • Diseases of the respiratory system
    • Alimentary tract and metabolic diseases
    • Diseases of the nervous system
    • Infectious diseases
    • Diseases of the musculoskeletal system
    • Eyesight diseases
  • Obesity
  • Smoking
  • Alcohol consumption
  • Consumer behaviour
    • Subjective assessment of health condition
    • Preventive health care
    • Use of OTC medications and dietary supplements
    • Factors affecting drug purchase
    • Places where OTC medications and dietary supplements are purchased
    • Sources of information about health and medicines
    • Approach to original and generic drugs
    • Evaluation of the healthcare system
  • Main legal acts and institutions regulating the Polish pharmaceutical market
  • Marketing authorisation
    • Medicinal products
    • Dietary supplements
  • General requirements: SmPC, packaging, leaflet
    • Summary of Product Characteristics
    • Packaging
    • Leaflet
  • Safety
    • Medicinal products
    • Dietary supplements
  • Parallel imports
  • Parallel exports
  • Direct distribution
  • Advertising
  • Intellectual property
  • Planned legal changes
  • Healthcare market in Poland
    • Healthcare expenditure in Poland
      • Total expenditure
      • Healthcare expenditure by purpose
      • NFZ expenditure
  • Medical personnel
  • Hospitals
    • Key data
    • Number of contracts with the NFZ
    • Value of contracts with the NFZ
  • Financial standing of Polish healthcare facilities
  • Remuneration in health care